These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9513440)

  • 21. [Urinary proteins in patients with diabetes mellitus].
    Hofmann W; Guder WG
    Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
    Galanti LM; Jamart J; Dell'omo J; Donckier J
    Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between urinary albumin excretion and plasma 5-hydroxyindole-3-acetic acid concentration in men with type 2 diabetes.
    Fukui M; Ose H; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Care; 2007 Oct; 30(10):2649-51. PubMed ID: 17623827
    [No Abstract]   [Full Text] [Related]  

  • 25. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients.
    Sejdiu I; Torffvit O
    Scand J Urol Nephrol; 2008; 42(2):168-74. PubMed ID: 17907053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [alpha 2-macroglobulin in urine. Significance for differential diagnosis of rejection and infections after kidney transplantation].
    Steinhoff J; Faerber P; Preuss R; Wood WG; Sack K
    Dtsch Med Wochenschr; 1994 Jan; 119(1-2):1-6. PubMed ID: 7506645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
    Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes.
    Humpert PM; Kopf S; Djuric Z; Wendt T; Morcos M; Nawroth PP; Bierhaus A
    Diabetes Care; 2006 May; 29(5):1111-3. PubMed ID: 16644647
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteomic approaches for discovering biomarkers of diabetic nephropathy.
    Ben Ameur R; Molina L; Bolvin C; Kifagi C; Jarraya F; Ayadi H; Molina F; Granier C
    Nephrol Dial Transplant; 2010 Sep; 25(9):2866-75. PubMed ID: 20472580
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteomic biomarkers in diabetic nephropathy--reality or future promise?
    Mischak H; Rossing P
    Nephrol Dial Transplant; 2010 Sep; 25(9):2843-5. PubMed ID: 20571095
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary biomarkers involved in type 2 diabetes: a review.
    Matheson A; Willcox MD; Flanagan J; Walsh BJ
    Diabetes Metab Res Rev; 2010 Mar; 26(3):150-71. PubMed ID: 20222150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [alpha 1-Acido glycoprotein].
    Suehiro T; Hashimoto K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():386-9. PubMed ID: 9513448
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study.
    Uehara Y; Makino H; Seiki K; Urade Y;
    Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary alpha 2-macroglobulin excretion rate in type 2 diabetic patients].
    Uchiyama H; Ito S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():341-6. PubMed ID: 9513440
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical significance of urinary alpha 2-macroglobulin excretion rate in non-insulin-dependent diabetes mellitus].
    Yamazaki M; Ito S; Shibata A
    Nihon Rinsho; 1990 Dec; 48 Suppl():519-24. PubMed ID: 1707995
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary excretion rate and clearance of IgG4 and alpha 2-macroglobulin in type 2 diabetic patients.
    Ito S; Yamazaki M; Usami A; Hanyu O; Tani N; Shibata A
    Horm Metab Res; 1995 Jun; 27(6):303-4. PubMed ID: 7557845
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria.
    Narita T; Fujita H; Koshimura J; Meguro H; Kitazato H; Shimotomai T; Kagaya E; Suzuki K; Murata M; Usami A; Ito S
    Horm Metab Res; 2001 Jun; 33(6):370-8. PubMed ID: 11456288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [alpha 2-Macroglobulin].
    Hanabusa T; Nanjo K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():106-8. PubMed ID: 9513397
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.